Loading company…
Meiogenix SAS, based in Paris, applies Chromosome Editing in agricultural biotechnology to broaden crop genetic diversity.
Founded in 2010 and headquartered in Paris, France, Meiogenix SAS works in agricultural biotechnology, using Chromosome Editing to enhance crop genetic diversity. It has completed four deals. On August 18, 2022, the company raised EUR 5.5 million in a round led by Sofinnova Partners. Luc Mathis is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in